Navigation Links
Neutrogena(R) Dermatologics Introduces skin iD(TM), the First Personalized Acne Solution
Date:6/12/2008

Clinically proven to be 2X more effective in acne clearing, and 2X more

effective in acne prevention vs. the leading acne system

LOS ANGELES, June 12 /PRNewswire/ -- Neutrogena(R) Dermatologics, a unit of the #1 dermatologist recommended skincare brand Neutrogena(R), introduces skin iD(TM), the first personalized acne solution clinically proven to treat and prevent acne. skin iD is a precise, targeted and individualized approach to treating and preventing acne.

(Photo: http://www.newscom.com/cgi-bin/prnh/20080612/NYTH030 )

In a clinical trial testing 500 people with different skin, acne and lifestyles, 100% of people using skin iD got clearer, healthier-looking skin. skin iD is currently the only non-prescription acne solution on the market that has conducted a double blind, randomized, placebo-controlled clinical trial -- the "gold standard" in testing methodology. This clinical trial demonstrated skin iD's power to work significantly better than the top selling acne regimen in treating 16 different signs of acne.

skin iD was developed by Neutrogena(R) Dermatologics with a group of leading dermatologists, scientists and market researchers, charged to create a customized skin-clearing solution specifically designed to treat acne on a case-by-case basis without a prescription. skin iD is comprised of a skin evaluation, an exclusive product line and a comprehensive Web site to treat each individual's acne needs.

Exclusively available on skiniD.com, and showcased through a series of infomercials, skin iD is the first proposition of its kind on the market. "We wanted to create a highly effective acne solution to meet the needs of individuals who are not satisfied with their existing acne regimen," states Jim Colleran, President, Neutrogena Corporation. "skin iD was developed with an innovative one-on-one approach. We determined that offering consumers access to skin iD through a dedicated Web site or by phone would allow for the dialogue necessary to evaluate their unique skincare needs and provide a personalized regimen."

skin iD utilizes a breakthrough skin and lifestyle evaluation tool, which contains a patent-pending algorithm that provides a personalized skincare regimen based on the specific skincare needs of each individual consumer. skin iD is formulated with two leading acne-fighting medicines, Salicylic Acid and Benzoyl Peroxide, included in more than 25 customized acne skincare regimens that cleanse, treat and protect for significantly improved skin.

To launch skin iD, Neutrogena(R) Dermatologics has enlisted singer/actress Katharine McPhee. Best known for her success on "American Idol" and her first single "Somewhere Over the Rainbow," McPhee is truly a role model for young girls, who understands the emotional impact associated with acne and the importance of finding a solution. Katharine will appear in infomercials and be featured on skiniD.com beginning in May 2008. McPhee will make her big screen debut in August, starring in "The House Bunny" opposite Anna Farris, Emma Stone and Kat Dennings for Sony Pictures.

About Neutrogena(R):

A worldwide leader in premium, dermatologist-recommended skin, hair and cosmetics products, Neutrogena(R) Corporation has been providing consumers with health and beauty improvements for over 40 years. The Company manufactures and markets a line of premium priced skin and hair care products that are distributed in more than 70 countries. Headquartered in Los Angeles, Neutrogena(R) is a subsidiary of Johnson & Johnson, world's most comprehensive and broadly based health care products company.


'/>"/>
SOURCE Neutrogena
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Update: Oscar-Nominated Actress Signs on as Neutrogena(R) Brand Ambassador
2. Oscar-Nominated Actress Signs on as Neutrogena(R) Brand Ambassador
3. Wolters Kluwer Health Introduces Formulary Facts(TM), a Formulary Analytics Tool that Sets the Standard for Accuracy and Ease-of-Use
4. IMTEC Introduces the SPRITE CT System
5. COSE Introduces Health Incentives, Wellness Programs for Medium-Size Businesses
6. Zebra Technologies Introduces HC100(TM) Patient I.D. Wristbanding Solution
7. PharMEDium Introduces Innovative New Admixture Label Design
8. Alaven Pharmaceutical Introduces Kit for UC Patients
9. Omron Healthcare Introduces New Device Drivers Built on Microsoft HealthVault
10. Answers From Nature Introduces 100% Non-China Ingredients for Dietary Supplements
11. Braemar Introduces the DL900 Advanced Holter Monitor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... Charlotte, NC (PRWEB) , ... June 26, 2016 , ... Brent Kasmer, a legally blind ... able to be personalized through a fitness app. The fitness app plans to fix the ... solutions currently only offer a one size fits all type program , They ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the ... several important health care topics including advance care planning, healthcare costs and patient ...
(Date:6/25/2016)... ... ... closing of Bruton Memorial Library on June 21 due to a possible lice infestation, as ... of head lice: the parasite’s ability to live away from a human host, and to ... one in the event that lice have simply gotten out of control. , As lice ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room ... Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson ... Recently, he has implemented orthobiologic procedures as a method for treating his patients. ... the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Research and Markets has announced the addition of ... report to their offering. ... kidney failure, it replaces the function of kidneys by removing ... thus the treatment helps to keep the patient body,s electrolytes ... Increasing number of ESRD patients & substantial healthcare expenditure ...
(Date:6/23/2016)... 2016 Research and Markets has ... by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), ... Parenteral) - Global Forecast to 2021" report to ... The global pharmaceutical excipients market is projected to reach ... 6.1% in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... 23, 2016 Roche (SIX: RO, ROG; OTCQX: ... its Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated ... shock. With this clearance, Roche is the first IVD ... solution for sepsis risk assessment and management. ... and PCT levels in blood can aid clinicians in ...
Breaking Medicine Technology: